Baseline Lactate Dehydrogenase Predicts Early Treatment Failure in Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A Real-World Cohort Study

Noorwati Sutandyo, Hilman Tadjoedin, Nia Novianti Siregar, Yuniar Harris Prayitno

Open source

DOI
10.14740/jocmr6583
Published
2026-06
Container
Journal of Clinical Medicine Research
Publisher
Elmer Press, Inc.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14740/jocmr6583,
  title = {Baseline Lactate Dehydrogenase Predicts Early Treatment Failure in Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A Real-World Cohort Study},
  author = {Noorwati Sutandyo and Hilman Tadjoedin and Nia Novianti Siregar and Yuniar Harris Prayitno},
  year = {2026},
  journal = {Journal of Clinical Medicine Research},
  doi = {10.14740/jocmr6583},
  url = {https://doi.org/10.14740/jocmr6583}
}

RIS

TY  - JOUR
TI  - Baseline Lactate Dehydrogenase Predicts Early Treatment Failure in Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A Real-World Cohort Study
AU  - Noorwati Sutandyo
AU  - Hilman Tadjoedin
AU  - Nia Novianti Siregar
AU  - Yuniar Harris Prayitno
PY  - 2026
JO  - Journal of Clinical Medicine Research
DO  - 10.14740/jocmr6583
UR  - https://doi.org/10.14740/jocmr6583
ER  - 

APA

Sutandyo, N., Tadjoedin, H., Siregar, N. N., & Prayitno, Y. H. (2026). Baseline Lactate Dehydrogenase Predicts Early Treatment Failure in Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A Real-World Cohort Study. Journal of Clinical Medicine Research. https://doi.org/10.14740/jocmr6583

Source records